Novo Nordisk B A/S

NOVO-B 
(NasdaqOMXC) 
 

To view this page ensure that Adobe Flash Player version 10.0.0 or greater is installed.

dkk 376.70 <%= Resources.Global.txtUp %>
Updated 13:54:37
ISIN: DK0060534915
Change % 1.26% Stock price increasing
Change 4.70 Stock price increasing
Volume 2,145,707
High DKK 381.70
Low DKK 369.30
Open DKK 372.00
 
Prev close DKK 372.00
# of shares 2,112.56M
Market cap 795,803M DKK
Intraday

Novo Nordisk B A/S
Market is open (until 16:00) - Delayed 15 min
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  376.70 10.6% Stock price increasing 17.8% Stock price increasing 44.7% Stock price increasing 32.7% Stock price increasing 54.1% Stock price increasing
Key Figures (m)
Turnover
EBIT
Net Profit
Equity
Balance
2014
88,806
34,492
26,481
40,294
77,062
2013
83,572
31,493
25,184
42,569
70,337
2012
78,026
28,142
21,432
40,632
65,669
2011
66,346
22,374
17,097
37,448
64,698
2010
60,776
18,891
14,403
36,965
61,402
2009
51,078
14,933
10,768
35,734
54,742
2008
45,666
12,405
9,666
33,058
0
2007
41,889
8,955
8,535
32,223
0

News about Novo Nordisk B A/S

  • English
  • Regulatory news

Company profile

Headquartered in Denmark, Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Targets for: Novo Nordisk B A/S

Ritzau Finans
 
Analyst
Target
Date
Novo/Goldman: Hæver kursmål til 375 kr. fra 345 kr.- fastholder
Goldman Sachs
375 op
27/03/15
Novo/SEB: Hæver kursmålet med 25 kr. til 400 kr.
SEB Enskilda
400 op
18/03/15
Novo/Jyske: Hæver kursmål fra 315 kr. til 350 kr.
Jyske Bank
350 op
27/01/15
Novo/Barclays: Hæver kursmål til 310 kr.
Barclays
310 op
16/01/15
Novo/JPM: Løfter kursmål til 315 kr. fra 280 kr. - NY
JPMorgan
315 op
05/01/15
Novo/JPM: Løfter kursmål til 315 kr. fra 280 kr.
JPMorgan
315 op
05/01/15
Novo/Exane: Indleder dækning med
BNP Paribas
270 ingen ændring
25/11/14
Novo/SEB: Hæver kursmål til 350 kr. fra 260 kr.
SEB Enskilda
350 op
20/05/14

Copyright Euroinvestor A/S 2015   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
01 April 2015 14:09:43
(UTC) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20150325.1 - EUROWEB4 - 2015-04-01 15:09:43 - 2015-04-01 14:09:43 - 1000 - Website: OKAY